rcfp-10
Biologicalexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2008 (NCT00793702)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Mycobacterium tuberculosisImmunity, active
Mycobacterium tuberculosis immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rcfp-10
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01033929 | Phase 1 | Jan 1, 2010 | Statens Serum Institut, University of London |
| NCT00793702 | Phase 1 | Nov 1, 2008 | Statens Serum Institut |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Statens Serum Institut | Academic/Hospital | 2 | 2 | 1 | 2008 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2010 |
2 organizations
Page 1 / 1